References/Publications for Basophil/Mast cell_Histamine Test of Phl p 1

Check all              

Select PubMed ID Description
8613635 J Allergy Clin Immunol. 1996 Mar;97(3):781-7.

Immunologic characterization of purified recombinant timothy grass pollen (Phleum
pratense) allergens (Phl p 1, Phl p2, Phl p 5).

Vrtala S(1), Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, Kraft D, Valenta
R.


10382766 Eur J Immunol. 1999 Jun;29(6):2026-36.

Induction of antibody responses to new B cell epitopes indicates vaccination
character of allergen immunotherapy.

Ball T(1), Sperr WR, Valent P, Lidholm J, Spitzauer S, Ebner C, Kraft D, Valenta
R.


10428753 FASEB J. 1999 Aug;13(11):1277-90.

B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by
gene fragmentation as candidates for immunotherapy.

Ball T(1), Fuchs T, Sperr WR, Valent P, Vangelista L, Kraft D, Valenta R.


11421902 Allergy. 2001 Jun;56(6):548-52.

Diagnostic evaluation of grass- and birch-allergic patients with oral allergy
syndrome.

Anhoej C(1), Backer V, Nolte H.


11511525 FASEB J. 2001 Sep;15(11):2042-4. Epub 2001 Jul 24.

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major
grass pollen allergen, Phl p 1, for allergy vaccination.

Focke M(1), Mahler V, Ball T, Sperr WR, Majlesi Y, Valent P, Kraft D, Valenta R.


17291855 J Allergy Clin Immunol. 2007 Feb;119(2):384-90. Epub 2006 Nov 7.

Molecular determinants of allergen-induced effector cell degranulation.

Gieras A(1), Focke-Tejkl M, Ball T, Verdino P, Hartl A, Thalhamer J, Valenta R.


17393727 Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006;(95):84-8;
discussion 88-90, 100-4.

Immune reactivity of candidate reference materials.

Fernandez-Rivas M(1), Aalbers M, Fötisch K, de Heer P, Notten S, Vieths S, van
Ree R.


19243361 Allergy. 2009 Apr;64(4):569-80. doi: 10.1111/j.1398-9995.2008.01910.x. Epub 2009
Feb 19.

Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for
allergy vaccination.

Ball T(1), Linhart B, Sonneck K, Blatt K, Herrmann H, Valent P, Stoecklinger A,
Lupinek C, Thalhamer J, Fedorov AA, Almo SC, Valenta R.


19414783 J Immunol. 2009 May 15;182(10):6298-306. doi: 10.4049/jimmunol.0713622.

A combination vaccine for allergy and rhinovirus infections based on
rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major
timothy grass pollen allergen Phl p 1.

Edlmayr J(1), Niespodziana K, Linhart B, Focke-Tejkl M, Westritschnig K,
Scheiblhofer S, Stoecklinger A, Kneidinger M, Valent P, Campana R, Thalhamer J,
Popow-Kraupp T, Valenta R.


20558998 Int Arch Allergy Immunol. 2010;153(4):323-34. doi: 10.1159/000316343. Epub 2010
Jun 17.

Effect on cell surface markers following allergen-induced desensitization of
human whole-blood basophils.

Lund G(1), Jacobi H, Skov PS, Holm J, Lund K.


23182706 Immunobiology. 2013 Jun;218(6):884-91. doi: 10.1016/j.imbio.2012.10.008. Epub
2012 Oct 26.

Passive immunization with allergen-specific IgG antibodies for treatment and
prevention of allergy.

Flicker S(1), Linhart B, Wild C, Wiedermann U, Valenta R.


23761636 J Immunol. 2013 Jul 15;191(2):551-60. doi: 10.4049/jimmunol.1202051. Epub 2013
Jun 12.

Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1
grass pollen allergen fragment.

Levin M(1), Rydnert F, Källström E, Tan LW, Wormald PJ, Lindstedt M, Greiff L,
Ohlin M.